You can buy or sell XFOR and other stocks, options, and ETFs commission-free!
X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Read More Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA. The listed name for XFOR is X4 Pharmaceuticals, Inc. Common Stock.
Paula S. Ragan, PhD
52 Week High
52 Week Low
— per share